U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT07453589) titled 'Small Bowel Ultrasound and Antibody Levels in Celiac Disease Activity' on March 02.
Brief Summary: This observational study aims to evaluate the relationship between small bowel ultrasound findings and tissue transglutaminase (tTG) antibody blood levels in assessing celiac disease activity. The traditional gold standard for diagnosing and monitoring celiac disease involves an invasive duodenal biopsy. Researchers want to determine if combining a painless, non-invasive small bowel ultrasound with tTG antibody blood tests can accurately predict disease severity and monitor a patient's response to a gluten-free diet.
The study will en...